Ectopic expression of alpha1,6 fucosyltransferase in mice causes steatosis in the liver and kidney accompanied by a modification of lysosomal acid lipase.

The alpha1,6 fucosyltransferase (alpha1,6 FucT) catalyzes the transfer of a fucose from GDP-fucose to the innermost GlcNAc residue of N-linked glycans via an alpha1,6 linkage. alpha1,6 FucT was overexpressed in transgenic mice under the control of a combined cytomegalovirus and chicken beta-actin promoter. Histologically numerous small vacuoles, in which lipid droplets had accumulated, were observed in hepatocytes and proximal renal tubular cells. Electron microscopic studies showed that the lipid droplets were membrane-bound and apparently localized within the lysosomes. Cholesterol esters and triglycerides were significantly increased in liver and kidney of the transgenic mice. Liver lysosomal acid lipase (LAL) activity was significantly lower in the transgenic mice compared to the wild mice, whereas LAL protein level, which was detected immunochemically, was increased, indicating that the specific activity of LAL was much lower in the transgenic mice. In all of the transgenic and nontransgenic mice examined, the activity of liver LAL was negatively correlated with the level of alpha1,6 FucT activity. As evidenced by lectin and immunoblot analysis, LAL was found to be more fucosylated in the transgenic mice, suggesting that the aberrant fucosylation of LAL causes an accumulation of inactive LAL in the lysosomes. Such an accumulation of inactive LAL could be a likely cause for a steatosis in the lysosomes of the liver and kidney in the case of the alpha1,6 FucT transgenic mice.

[1]  K. Scarbrough Use of antisense oligodeoxynucleotides to study biological rhythms. , 2000, Methods.

[2]  K. Sandhoff,et al.  Sphingolipid hydrolases and activator proteins. , 2000, Methods in enzymology.

[3]  J. Reddy,et al.  Peroxisomal and Mitochondrial Fatty Acid β-Oxidation in Mice Nullizygous for Both Peroxisome Proliferator-activated Receptor α and Peroxisomal Fatty Acyl-CoA Oxidase , 1999, The Journal of Biological Chemistry.

[4]  J. Ibdah,et al.  A Fetal Fatty-Acid Oxidation Disorder as a Cause of Liver Disease in Pregnant Women , 1999 .

[5]  Martin Merkel,et al.  Lysosomal Acid Lipase , 1999 .

[6]  D. Witte,et al.  Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage. , 1998, Human molecular genetics.

[7]  J. Miyazaki,et al.  Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice. , 1998, Human gene therapy.

[8]  F. Baralle,et al.  New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. , 1998, Journal of lipid research.

[9]  P. Somerharju,et al.  Direct observation of lipoprotein cholesterol ester degradation in lysosomes. , 1998, Biochemical Journal.

[10]  K. Yamamura,et al.  Ectopic expression of N-acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Newell,et al.  An IgG monoclonal antibody against Dictyostelium discoideum glycoproteins specifically recognizes Fucalpha1,6GlcNAcbeta in the core of N-linked glycans. Localized expression of core-fucosylated glycoconjugates in human tissues. , 1997, The Journal of biological chemistry.

[12]  Naoyuki Taniguchi,et al.  Expression of α1‐6 fucosyltransferase in rat tissues and human cancer cell lines , 1997 .

[13]  P. Robbins,et al.  An important developmental role for oligosaccharides during early embryogenesis of cyprinid fish. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  N Taniguchi,et al.  Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells. , 1997, Journal of biochemistry.

[15]  F. Baralle,et al.  L273S missense substitution in human lysosomal acid lipase creates a new N‐glycosylation site , 1996, FEBS letters.

[16]  Naoyuki Taniguchi,et al.  Purification and cDNA Cloning of Porcine Brain GDP-L-Fuc:N-Acetyl-β-D-Glucosaminide α1→6Fucosyltransferase* , 1996, The Journal of Biological Chemistry.

[17]  J. Reddy,et al.  Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene* , 1996, The Journal of Biological Chemistry.

[18]  R. Pullarkat,et al.  Brain lysosomal hydrolases in neuronal ceroid-lipofuscinoses. , 1996, Molecular and chemical neuropathology.

[19]  R. Hammer,et al.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. , 1996, The Journal of clinical investigation.

[20]  N Taniguchi,et al.  A fluorescent assay method for GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha 1-6fucosyltransferase activity, involving high performance liquid chromatography. , 1996, Journal of biochemistry.

[21]  K. Reue,et al.  Naturally occurring mutations in mice affecting lipid transport and metabolism. , 1996, Journal of lipid research.

[22]  D. Witte,et al.  Tissue and cellular specific expression of murine lysosomal acid lipase mRNA and protein. , 1996, Journal of lipid research.

[23]  H. Du,et al.  Characterization of Lysosomal Acid Lipase by Site-directed Mutagenesis and Heterologous Expression (*) , 1995, The Journal of Biological Chemistry.

[24]  M. Osame,et al.  Cloning of rat lysosomal acid lipase cDNA and identification of the mutation in the rat model of Wolman's disease. , 1995, Journal of lipid research.

[25]  R. Dwek Glycobiology: more functions for oligosaccharides , 1995, Science.

[26]  N. Matsuki,et al.  Defect in assembly process of very-low-density lipoprotein in suncus liver: an animal model of fatty liver. , 1995, Journal of biochemistry.

[27]  D. Hale,et al.  The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Saito,et al.  Cholesterol metabolism in monocyte-derived macrophages from macrophage colony-stimulating factor administered rabbits. , 1995, Biochimica et biophysica acta.

[29]  R. Anderson,et al.  Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Eckerskorn,et al.  Purification, characterization and molecular cloning of human hepatic lysosomal acid lipase. , 1994, European journal of biochemistry.

[31]  K. Lovell,et al.  Biochemical and histochemical analysis of lysosomal enzyme activities in caprine β-mannosidosis , 1994 .

[32]  K. Tanikawa,et al.  A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. , 1993, Cancer research.

[33]  S. Nagataki,et al.  Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. , 1993, The New England journal of medicine.

[34]  J. Chi,et al.  Leigh's disease involving multiple organs. , 1993, Journal of Korean medical science.

[35]  D. Rader,et al.  Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. , 1992, Science.

[36]  M. Du,et al.  Fucosyltransferases: Differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis , 1991, Hepatology.

[37]  M. Kuriyama,et al.  Genetic lipid storage disease with lysosomal acid lipase deficiency in rats. , 1990, Laboratory animal science.

[38]  C. Degott,et al.  Microvesicular steatosis of the liver. , 1990, Acta clinica Belgica.

[39]  N. Kochibe,et al.  Cloning and expression of a functional fucose‐specific lectin from an orange peel mushroom, Aleuria aurantia , 1989, FEBS letters.

[40]  G. Labbe,et al.  Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic , 1988, Hepatology.

[41]  E. Werner,et al.  POTENTIAL OF URINARY NEOPTERIN EXCRETION IN DIFFERENTIATING CHRONIC NON-A, NON-B HEPATITIS FROM FATTY LIVER , 1987, The Lancet.

[42]  K. Ishak,et al.  Liver disease in pregnancy , 1986, Histopathology.

[43]  L. Rosenbaum,et al.  Human lysosomal acid lipase/cholesteryl ester hydrolase. Purification and properties of the form secreted by fibroblasts in microcarrier culture. , 1985, The Journal of biological chemistry.

[44]  D. Slater,et al.  Renal morphological changes in idiopathic acute fatty liver of pregnancy , 1984, Histopathology.

[45]  Y. Sameshima,et al.  Lipolysosomes in Human Hepatocytes: Their Increase in Number Associated with Serum Level of Cholesterol in Chronic Liver Diseases , 2007, Hepatology.

[46]  H. Gonen,et al.  A serum protein inhibitor of acid lipase and its possible role in lipid accumulation in cultured fibroblasts. , 1982, The Biochemical journal.

[47]  Y. Matsuzawa,et al.  Apo A-I and apo A-II inhibit hepatic triglyceride lipase from human postheparin plasma. , 1981, Biochemical and biophysical research communications.

[48]  R. Wenk,et al.  Tetracycline-associated fatty liver of pregnancy, including possible pregnancy risk after chronic dermatologic use of tetracycline. , 1981, The Journal of reproductive medicine.

[49]  P. Lazarow Assay of peroxisomal beta-oxidation of fatty acids. , 1981, Methods in enzymology.

[50]  G. Kolata Reye's syndrome: a medical mystery. , 1980, Science.

[51]  P. Brady,et al.  Abnormalities of hepatic mitochondrial urea-cycle enzyme activities and hepatic ultrastructure in acute fatty liver of pregnancy. , 1979, The Journal of laboratory and clinical medicine.

[52]  J. Ontko,et al.  Activation of mitochondrial fatty acid oxidation by calcium. Conversion to the energized state. , 1978, The Journal of biological chemistry.

[53]  D. Winship,et al.  Lipolysosomes in human liver: distribution in livers with fatty infiltration. , 1977, Gastroenterology.

[54]  J. Lough,et al.  Wolman's disease. An electron microscopic, histochemical, and biochemical study. , 1970, Archives of pathology.

[55]  V. Rodwell,et al.  Thin-layer chromatographic assay for HMG-CoA reductase and mevalonic acid. , 1969, Analytical biochemistry.

[56]  J. Martín,et al.  Wolman's disease. , 1968, European neurology.